Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Coronavirus in the Histology Laboratory
...
Already a member? Log in here
FDA Takes Unprecedented Measures to Promote Rapid Development of Coronavirus Diagnostic Tests
...
Already a member? Log in here
TOOL: Model Screening Form For Coronavirus COVID-19
...
Already a member? Log in here
CMS Develops Additional Code for Coronavirus Lab Tests
...
Already a member? Log in here
Top of the News: CMS Issues New Guidance for Laboratories Performing Coronavirus Testing
On Feb. 4, the Food and Drug Administration (FDA) granted emergency use authorization (EUA) clearance for the first test approved in the US for detecting the novel coronavirus. Developed by the US Centers for Disease Control and Prevention (CDC) using sequencing...
Point of Care: Is the Blood-Drawing Robot the Phlebotomist of the Future?
...
Already a member? Log in here
FDA Watch: Agency Grants Emergency Clearance for CDC Novel Coronavirus Detection Test
...
Already a member? Log in here
Strategic planning needs to evolve over time
...
Already a member? Log in here
Agency to Use EUA Pathway to Clear New Coronavirus Detection Tests
...
Already a member? Log in here
